NASDAQ:ABVC ABVC BioPharma (ABVC) Stock Forecast, Price & News $0.94 +0.06 (+6.82%) (As of 09/25/2023 ET) Add Compare Share Share Today's Range$0.88▼$1.0350-Day Range$0.88▼$5.3252-Week Range$0.82▼$18.70Volume42,323 shsAverage Volume79,975 shsMarket Capitalization$3.71 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media About ABVC BioPharma (NASDAQ:ABVC) StockABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1703, which is in Phase II clinical trials for the treatment of metastatic pancreatic cancer; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; ABV-1601 that is in Phase I/II clinical trials for treating depression in cancer patients; ABV-1701 Vitargus that is in Phase II clinical trials for the treatment of retinal detachment or vitreous hemorrhage; and ABV-1519, which is in Phase I/II clinical trials for the treatment of non-small cell lung cancer. ABVC BioPharma, Inc. has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California. ABVC BioPharma, Inc. is a subsidiary of YuanGene Corporation.Read More ABVC Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ABVC Stock News HeadlinesAugust 23, 2023 | finance.yahoo.comABVC BioPharma Provides Updates on ADHD Phase IIb Clinical StudyAugust 17, 2023 | markets.businessinsider.comABVC BioPharma Enters Into Agreement To Exchange 20% Stake In Real Estate Property Of ZhonghuiSeptember 26, 2023 | Wall Street Fundamentals (Ad)How is This "Hidden Gem" Thriving in a Turbulent Market?While Wall Street flounders and giants like Amazon & Microsoft lay off thousands... One overlooked company has been quietly achieving over 400% growth. How? By buying, building, and scaling a portfolio of promising brands in high-margin, recession-resistant verticals.August 17, 2023 | finance.yahoo.comABVC Executes Cooperation Agreement for Strategic InvestmentsAugust 10, 2023 | finanznachrichten.deABVC BioPharma, Inc.: ABVC BioPharma Regains Compliance With Nasdaq's Minimum Bid Price RequirementAugust 10, 2023 | finance.yahoo.comABVC BioPharma Regains Compliance With Nasdaq's Minimum Bid Price RequirementAugust 7, 2023 | finanznachrichten.deABVC BioPharma, Inc.: ABVC Corporate Update and CEO's Letter to ShareholdersAugust 7, 2023 | finance.yahoo.comABVC Corporate Update and CEO's Letter to ShareholdersSeptember 26, 2023 | Edge On The Street (Ad)Gold Could Be Heading for Record Highs - But How to Play It?According to FX Empire, the gold forecast is now bullish, with support for a $3,000 target in 2024. The big question is how to play it. Some investors are discovering a unique gold investment alternative that sidesteps the major issues with gold mining stocks or physical gold. August 3, 2023 | finance.yahoo.comABVC Announces the Approval of the Plan for GMP Production Facilities of Vitargus by Taiwan Science Park AdministrationAugust 2, 2023 | benzinga.comThinking about buying stock in Tupperware Brands, Archer Aviation, Apellis Pharmaceuticals, Adamis Pharmaceuticals, or ABVC BioPharma?August 1, 2023 | marketwatch.comABVC Biopharma Shares Rise 58% After Licensing Deal for ChinaAugust 1, 2023 | msn.comABVC stock rallies on Chinese licensing deal for psych drugsAugust 1, 2023 | finance.yahoo.comABVC Signs a Term Sheet to Earn Licensing Fees of up to $20M and Royalties of 5-12% of Net SalesJuly 31, 2023 | finance.yahoo.comABVC BioPharma Announces Closing on $1.75 Million Registered Direct OfferingJuly 28, 2023 | marketwatch.comABVC BioPharma Shares Hit 52-Week Low After Direct Offering PricesJuly 28, 2023 | msn.comABVC BioPharma down 34%, prices $1.75M direct offeringJuly 27, 2023 | marketwatch.comABVC BioPharma Shares Drop 19% After Direct Offering PricesJuly 27, 2023 | finance.yahoo.comABVC BioPharma Announces Pricing of $1.75 Million Registered Direct OfferingJuly 27, 2023 | benzinga.comWhy ABVC Biopharma Stock Is Roaring HigherJuly 27, 2023 | marketwatch.comABVC BioPharma Shares Up 44% After Co. Signs Term Sheet for Real Estate AssetsJuly 25, 2023 | benzinga.comWhy ABVC Biopharma Stock Is Trading HigherJuly 25, 2023 | finanznachrichten.deABVC BioPharma, Inc.: ABVC BioPharma Announces Reverse Stock SplitJuly 6, 2023 | finanznachrichten.deABVC BioPharma, Inc.: The New CEO of ABVC BioPharma Takes Steps to Help Improve Cash EfficiencyJuly 6, 2023 | finance.yahoo.comThe New CEO of ABVC BioPharma Takes Steps to Help Improve Cash EfficiencyJune 26, 2023 | msn.comABVC BioPharma names Patil as new CEOJune 26, 2023 | benzinga.comABVC BioPharma shares are trading higher after the company appointed Uttam Yashwant Patil as the new Chief Executive Officer.See More Headlines Receive ABVC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ABVC BioPharma and its competitors with MarketBeat's FREE daily newsletter. Email Address ABVC Company Calendar Last Earnings8/14/2023Today9/26/2023Next Earnings (Estimated)11/13/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:ABVC CUSIPN/A CIK1173313 Webwww.abvcpharma.com Phone(510)-668-0881FaxN/AEmployees19Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($3.88) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-16,420,000.00 Net Margins-1,607.06% Pretax Margin-1,495.69% Return on Equity-477.58% Return on Assets-121.75% Debt Debt-to-Equity Ratio1.85 Current Ratio0.37 Quick Ratio0.37 Sales & Book Value Annual Sales$970,000.00 Price / Sales3.83 Cash FlowN/A Price / Cash FlowN/A Book Value$0.99 per share Price / Book0.95Miscellaneous Outstanding Shares3,950,000Free Float2,410,000Market Cap$3.71 million OptionableNot Optionable Beta0.32 The Best High-Yield Dividend Stocks for 2023Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Eugene Jiang (Age 37)Chairman & Chief Bus. Officer Comp: $200kMr. Leeds Chow (Age 34)CFO & Principal Accounting Officer Comp: $130kDr. Tsung-Shann Jiang EMBA (Age 69)Ph.D., Chief Scientific Officer & Director Comp: $200kDr. Uttam Yashwant Patil Ph.D.Chief Exec. OfficerKey CompetitorsPainReformNASDAQ:PRFXCyclacel PharmaceuticalsNASDAQ:CYCCHillstream BioPharmaNASDAQ:HILSSoligenixNASDAQ:SNGXGraybug VisionNASDAQ:GRAYView All Competitors ABVC Stock - Frequently Asked Questions Should I buy or sell ABVC BioPharma stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for ABVC BioPharma in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ABVC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ABVC, but not buy additional shares or sell existing shares. View ABVC analyst ratings or view top-rated stocks. How have ABVC shares performed in 2023? ABVC BioPharma's stock was trading at $6.25 at the start of the year. Since then, ABVC shares have decreased by 85.0% and is now trading at $0.94. View the best growth stocks for 2023 here. Are investors shorting ABVC BioPharma? ABVC BioPharma saw a decline in short interest during the month of August. As of August 31st, there was short interest totaling 19,800 shares, a decline of 29.8% from the August 15th total of 28,200 shares. Based on an average daily trading volume, of 791,400 shares, the days-to-cover ratio is presently 0.0 days. Currently, 1.0% of the shares of the company are short sold. View ABVC BioPharma's Short Interest. When is ABVC BioPharma's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023. View our ABVC earnings forecast. How were ABVC BioPharma's earnings last quarter? ABVC BioPharma, Inc. (NASDAQ:ABVC) issued its quarterly earnings data on Monday, August, 14th. The company reported ($0.68) EPS for the quarter. The business earned $0.01 million during the quarter. ABVC BioPharma had a negative trailing twelve-month return on equity of 477.58% and a negative net margin of 1,607.06%. When did ABVC BioPharma's stock split? Shares of ABVC BioPharma reverse split before market open on Tuesday, July 25th 2023. The 1-10 reverse split was announced on Tuesday, July 25th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, July 25th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. When did ABVC BioPharma IPO? (ABVC) raised $7 million in an initial public offering (IPO) on Tuesday, August 3rd 2021. The company issued 1,100,000 shares at $6.25 per share. What is ABVC BioPharma's stock symbol? ABVC BioPharma trades on the NASDAQ under the ticker symbol "ABVC." How do I buy shares of ABVC BioPharma? Shares of ABVC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is ABVC BioPharma's stock price today? One share of ABVC stock can currently be purchased for approximately $0.94. How much money does ABVC BioPharma make? ABVC BioPharma (NASDAQ:ABVC) has a market capitalization of $3.71 million and generates $970,000.00 in revenue each year. The company earns $-16,420,000.00 in net income (profit) each year or ($3.88) on an earnings per share basis. How can I contact ABVC BioPharma? ABVC BioPharma's mailing address is 44370 Old Warm Springs Boulevard, Fremont, CA 94538, United States. The official website for the company is www.abvcpharma.com. The company can be reached via phone at (510)-668-0881. This page (NASDAQ:ABVC) was last updated on 9/26/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ABVC BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.